CDMO Activity Tracker: Lupin’s CDMO commissions oncology block in India; Cambrex, Axplora, Hovione expand operations

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

MIGERGOT

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

66 API Suppliers, 10 USDMF, 10 CEP/COS, 11 JDMF, 1 EU WC, 7 KDMF, 18 NDC API, 31 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

125 Drugs in Development

125 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

511 FDF Dossiers, 126 FDA Orange Book, 128 Europe, 38 Canada, 129 South Africa, 90 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 356.4MG;30MG;16MG, TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 325MG;50MG;40MG;30MG, CAPSULE;ORAL - 325MG;50MG;40MG;30MG, TABLET;ORAL - 250MG;250MG;65MG, TABLET;ORAL - 100MG;1MG, TABLET;ORAL - 325MG;50MG;40MG, SUPPOSITORY;RECTAL - 100MG;2MG, TABLET;ORAL - 325MG;50MG;40MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 1 Evonik, 13 Rochem International Inc, 31 SPI Pharma, 31 DKSH, 2 Pharm-RX Chemical, 9 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 1 ICE Pharma, 16 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 1 Capital Farma, 13 Kirsch Pharma, 4 ACG Worldwide, 21 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 Ashland, 46 BASF, 1 Bioplus Life Sciences, 3 CD Formulation, 4 Clariant, 13 Corel Pharma Chem, 7 DFE Pharma, 2 Esteem Industries, 3 Finar, 15 Gangwal Chemicals, 1 Hayashibara, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 26 Kerry, 4 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 2 Lubrizol Life Science Health, 26 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 11 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 46 Roquette, 20 Seppic, 3 Shandong Focus Biotechnology Co., Ltd, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 5 Silverline Chemicals, 1 Symrise, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem, 3 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

110 Fillers, Diluents & Binders, 75 Thickeners and Stabilizers, 61 Topical, 61 Coating Systems & Additives, 58 Solubilizers, 49 Disintegrants & Superdisintegrants, 49 Direct Compression, 46 Parenteral, 45 Taste Masking, 42 Granulation, 33 Controlled & Modified Release, 30 Film Formers & Plasticizers, 27 Emulsifying Agents, 27 Lubricants & Glidants, 26 Chewable & Orodispersible Aids, 20 Surfactant & Foaming Agents, 18 Rheology Modifiers, 18 Co-Processed Excipients, 12 API Stability Enhancers, 9 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

33 News #PharmaBuzz

33 News #PharmaBuzz

GLOBAL SALES INFORMATION

38 US Medicaid Prescriptions, 6 Regulatory FDF Prices

MARKET PLACE

89 APIs, 4 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM, 2 JP, 15 Others

ANALYTICAL

1 BioAnalytical Methods, 13 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
30/12/2025	Siegfried AG	Switzerland	CTC Bio Co., Ltd.	20220808-211-J-1341	Caffeine anhydrous	2022-08-08	Siegfried PharmaChemikalien Minden GmbH	Germany	Karlstraße 15-39, 42-44 32423 Minden, Germany
30/12/2025	CSPC New Nova Pharmaceutical	China	IMCD Korea Co., Ltd.	20250422-210-J-1875(3)	Caffeine anhydrous	2025-12-19	CSPC Innovation Pharmaceutical Co., Ltd.	China	No. 62 Zhangju Road, Luancheng County, Shijiazhuang City, Hebei Province, China

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

MIGERGOT

MIGERGOT

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

66 API Suppliers

10 USDMF

10 CEP/COS

11 JDMF

1 EU WC

7 KDMF

18 NDC API

31 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

125 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

511 FDF Dossiers

126 FDA Orange Book

128 Europe

38 Canada

129 South Africa

90 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 356.4MG;30MG;16MG

TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 325MG;50MG;40MG;30MG

CAPSULE;ORAL - 325MG;50MG;40MG;30MG

TABLET;ORAL - 250MG;250MG;65MG

TABLET;ORAL - 100MG;1MG

TABLET;ORAL - 325MG;50MG;40MG

SUPPOSITORY;RECTAL - 100MG;2MG

TABLET;ORAL - 325MG;50MG;40MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Minakem

1 Evonik

13 Rochem International Inc

31 SPI Pharma

31 DKSH

2 Pharm-RX Chemical

9 Boai NKY Pharmaceuticals Ltd

9 Gangwal Healthcare

1 ICE Pharma

16 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

1 Capital Farma

13 Kirsch Pharma

4 ACG Worldwide

21 Actylis

2 Aeon Procare

1 Alcedo Pharmachem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 Ashland

46 BASF

1 Bioplus Life Sciences

3 CD Formulation

4 Clariant

13 Corel Pharma Chem

7 DFE Pharma

2 Esteem Industries

3 Finar

15 Gangwal Chemicals

1 Hayashibara

5 Ideal Cures

5 Ingredion Pharma Solutions

26 Kerry

4 Keval Exports

5 Kima Chemical

6 Lonza Capsugel

2 Lubrizol Life Science Health

26 Microlex e.U

1 Nanjing Bold Chemical

2 Nippon Fine Chemical

2 Nitika Pharmaceutical Specialities

TABLET;ORAL - 325MG;50MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons